Cannae (CNNE) director gets 7,818 shares; holdings at 11,785
Cannae Holdings (CNNE) reported an insider equity award on Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cannae Holdings (CNNE) reported an insider equity award on Form 4. A company director received 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a standard restricted stock grant.
The award vests in three equal annual installments beginning November 12, 2026. Following this transaction, the director beneficially owns 11,785 shares, held directly. This filing indicates routine director compensation via restricted stock with a multi‑year vesting schedule.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,818 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock vesting in three equal annual installments beginning November 12, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cannae Holdings (CNNE) disclose on this Form 4?
What type of security was granted to the CNNE director?
Was this a purchase on the open market?
Is there any derivative security activity reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.